Remote ischemic postconditioning (RIPC) is a promising neuroprotective strategy for ischemic stroke. Here, we employed a focal ischemic stroke mouse model to test the hypothesis that poststroke collateral circulation as a potent mechanism of action underlying the therapeutic effects of immediate RIPC. During reperfusion of cerebral ischemia, the mice were randomly assigned to receive RIPC, granulocyte colony- Revascularization is a major endogenous defense mechanism in the brain after stroke. Accumulating evidence suggests that the early phase of cerebral blood volume (CBV) increase is likely due to the improvement in collateral flow, also known as arteriogenesis, whereas the late phase CBV increase is attributed to a surge of angiogenesis (J. wileyonlinelibrary.com/journal/jcp | 12637
adaptive progress can be augmented by exogenous growth factors (van Oostrom, van Oostrom, Quax, Verhaar, & Hoefer, 2008) . G-CSF in particular has been fairly well investigated for treating cerebral ischemia (Dela Peña et al., 2015; England, Gibson, & Bath, 2009) , likely in part due to its upregulation of collateral growth through monocyte recruitment (Sugiyama et al., 2011) .
Remote ischemic postconditioning (RIPC) is an intriguing treatment modality whereby ischemia induced in a distant nonvital organ, when applied immediately after the ischemic insult, offers protection (Andreka et al., 2007) . Numerous reports in animals and clinical trials have demonstrated the neuroprotective effect of RIPC against brain injury after stroke (Hess, Hoda, & Bhatia, 2013; Meng et al., 2012; Ren et al., 2009 Ren et al., , 2011 .
Multiple mechanisms have been proposed for RIPC-mediated protection, including decreased expression of inflammatory mediators (Kong, Rogers, & Qin, 2013) , increase of AKT/GSK3β-dependent autophagy (Qi et al., 2012) , and attenuation of bloodbrain barrier disruption by inhibition of MMP-9 activity and occludin degradation (Ren et al., 2015) . However, the underlying mechanisms contributing to RIPC are complex and remain poorly elucidated (Hess et al., 2015; Zhao, Ren, Chen, & Shen, 2012) .
Here, using G-CSF as a positive control, we examined the effect of RIPC on monocyte recruitment and subsequent leptomeningeal collateral circulation in mice with ischemic stroke.
| MATERIALS AND METHODS

| Animal experimental protocol
Male C57BL/6J strain mice 9-10 weeks of age; Charles River Laboratories Inc., Beijing, China) were used in this study. The experimental procedures were approved by the Animal Care and Use Committee of Capital Medical University, China, and conducted according to National Institutes of Health guidelines.
Focal cerebral ischemia was generated on a modified 3-vessel occlusion (3VO) method as reported by Z. Liu et al. (2017) . Briefly, general anesthesia was induced and maintained with 1.0-2.5% enfluane in 70% N 2 O and 30% O 2 (Bickford veterinary anesthesia equipment model no. 61010; AM Bickford Inc., Wales Center, NY). Under anesthesia, bilateral common carotid arteries (CCAs) were clipped for 15 min using surgical miniclips, whereas the stem of right distal middle cerebral artery (dMCA) was permanently cauterized using a bipolar coagulator (B. Braun Aesculap, Melsungen, Germany) through a 1-mmdiameter burr hole in the skull. Surgery was performed under a microscope (Carl Zeiss AG, Jena, Germany). A circulating heating pad and a heating lamp were used to keep rectal temperature at 37℃.
Sham-operated mice were exposed to the same conditions, but the dMCA and the CCAs were not manipulated. Stroke animals were randomly divided into three groups: (a) Stroke without treatment: 3VO followed by 24 hr of reperfusion; (b) Stroke&RIPC: RIPC was conducted immediately after CCAs release as described previously (Ren et al., 2011) , generally by occluding and releasing the femoral arteries in bilateral lower limbs for three cycles; each occlusion/release lasted for 10 min; (c) Stroke&G-CSF: recombinant human G-CSF, 100 µg/kg body weight in 100 µl sterile saline, sc., immediately after the operation. All studies were performed in a blinded and randomized manner.
| Neurological testing
The corner test was used to examine stroke severity and functional deficits (Zhang et al., 2002 ). Each mouse was tested for 20 trials and the laterality index was calculated according to the formula: laterality index = (turns to the right side − turns to the left side)/total number of turns. A laterality index of 0 is indicative of animals presenting total symmetry. This test detects integrated sensorimotor function as it involves both stimulation of the vibrissae (sensory/neglect) and rearing (motor response).
| Infarct volume measurements
Twenty-four hours after surgery, mice were anesthetized with 10% chloral hydrate. Coronal brain sections with a 1-mm thickness were removed, and stained with 2% solution of 2,3,5-triphenyltetrazolium chloride (Sigma-Aldrich Corp., St. Louis, MO). To correct hemispheric edema, infarct volume of the ischemic region was normalized to the nonischemic region and expressed as a percentage of contralateral cortex volume.
| Visualization of vessels by latex perfusion
The leptomeningeal anastomoses were visualized by latex perfusion technique as previously reported (Woitzik, Hecht, Schneider, Peña-Tapia, & Vajkoczy, 2006) . The mice were anesthetized with 1% enfluane in 70% N 2 O and 30% O 2 , and papaverine hydrochloride solution was slowly injected through the femoral vein at a rate of 100 µl/min (50 mg/kg body weight), then the right atrium of the heart was incised for the venous blood drain out. The left ventricle of the heart was cannulated and injected with 2 ml saline and subsequently 0.5 ml latex compound (Product No. 39210; UHU GmbH & Co. KG, Bühl/Baden, Germany), which was mixed with 50 µl/ml carbon black (Beijing Ink Product No. 1022-1144; Beijing, China) beforehand. Then, the brain was removed carefully from the skull, and photographs of the dorsal and ventral brain surface were taken by a scanner (Scanjet G3110; HP, Shanghai, China).
The vessel diameters of the leptomeningeal anastomoses were measured at the point where the distal MCA joined the distal anterior cerebral artery (ACA). The vessel diameter of the Willis' circle was measured at the proximal point where the right ACA diverged the olfactory artery.
| Immunostaining of monocytes/ macrophages (MMs)
Immunostaining was carried out at 24 hr after ischemic stroke. Mice were transcardially perfused with 0.9% NaCl, followed by 4% paraformaldehyde. Five-micron-thick paraffin-embedded slices were stained with anti-macrophage antibody (MAC387; 1:100; Abcam, Cambridge, UK) and then with Alexa 594-conjugated goat anti-mouse secondary antibody (1:400; Thermo Fisher Scientific, Rockford).
Images were captured using a microscope (Nikon, Tokyo, Japan).
| Monocyte depletion
Monocyte depletion was achieved by a single intraperitoneal injection of 5-fluorouracil (5-FU) 4 days before cerebral ischemic injury (150 mg/kg).
To verify the monocyte depletion, blood analysis was performed by flow cytometry at 4 and 7 days after the injection during preliminary test.
| Western blot analysis
At 24 hr mice were transcardially perfused with 0.9% NaCl, and total protein was extracted from the bilateral cortices. Protein concentration determination and western blot analysis were performed as our previous report (Wei et al., 2016) . The amount of proteins were quantified by densitometry and normalized to β-actin, an internal standard. Primary antibodies purchased were as follows: rabbit anti-angiopoietin 1 polyclonal antibody (1:500; Abcam), rabbit anti-Angiopoietin-2 polyclonal antibody (1:1000; Abcam); mouse anti-β-actin monoclonal antibody 
| Enzyme-linked immunoassay (ELISA)
The levels of mouse G-CSF and human G-CSF in mouse plasma and brain cortex homogenate were determined by ultrasensitive ELISA kits (R&D Systems, Inc), according to the manufacturer's instructions.
Before assay, mouse plasma samples were 10-fold diluted whereas brain cortex homogenate two-fold, and 50 µL or 100 µL of diluted sample was added per well for mouse G-CSF or human G-CSF detection, respectively. Absorbance was read using a microplate reader set to 450 nm, and wavelength correction at 540 nm.
| Statistical analysis
All data were expressed as mean ± SEM. Statistical analysis was performed with SPSS for Windows (version 22, SPSS Inc., Armonk).
The differences among groups were assessed using one-way analysis of variance, followed by all pairwise multiple comparison procedures using the Bonferroni test. Statistical significance was set at p ≤ 0.05.
| RESULTS
| Reduction of cerebral infarct volume and neurological deficit by RIPC
After 24 hr of ischemic stroke, a significant increase in corner test score (asymmetry) was observed in the Stroke group (−0.7 ± 0.1), which was significantly reduced by both RIPC (−0.2 ± 0.1, p < 0.001 vs. Stroke) and G-CSF treatments (−0.1 ± 0.1, p < 0.001 vs. Stroke; Figure 1a ). Additionally, infarct volume in the Stroke group was 45.4% ± 0.7% whereas Stroke&RIPC mice displayed significantly reduced infarct volume (31.8 ± 1.8%) compared with nontreated animals (p < 0.001). The Stroke&G-CSF group showed a greater decrease in cerebral infarct volume than RIPC treated stroke mice (26.4 ± 1.1%, p < 0.05 vs. Stroke&RIPC group; Figure 1b ).
| Enhanced leptomeningeal anastomoses growth by RIPC
The effect of RIPC on leptomeningeal anastomoses development was assessed at 24 hr after 3VO by quantitative measurement of F I G U R E 1 Infarct volume reduction and neurological function improvement by remote ischemic postconditioning. (a) At 24 hr, mice subjected to focal cerebral ischemic stroke showed asymmetry in turning preference, demonstrating impaired motor function, whereas the treatment groups reduced neurological deficit compared with nontreated animals; no further difference was observed between the two treatment groups (***p < 0.001 vs. Sham, Figure 2d ). There was a >70% macrophage decrease in the spleens of 0.18% ± 0.01%, vs. Stroke: 0.18% ± 0.01%, spleen/BW (%); Figure   4c ). Moreover, RIPC and G-CSF mice pretreated with 5-FU exhibited no reduction in cerebral infarct volume compared with nontreated stroke animals (Stroke&RIPC: 42.6% ± 1.0%, Stroke&G-CSF:
41.6% ± 1.3%, vs. Stroke: 39.2% ± 1.3%; Figure 4d ).
| Angioprotein-expression assay in ischemic cortex by western blot analysis
Ang-1 and Ang-2 were selected as markers of angiogenesis. There were no significant differences of Ang-1 expression between groups (Figure 5a ). Meanwhile ischemic insult upregulated Ang-2 expression in the ischemic cortex, whereas both treatments of RIPC and G-CSF showed no additional increase (Figure 5b ).
| G-CSF levels in mouse brain and plasma
Both mouse G-CSF and human G-CSF levels in brain and serum from 20 mice were determined by ELISA (n = 5 per group). Mouse G-CSF in each contralateral cortex sample was 0 pg (Figure 6a As for human G-CSF, it was only detected exclusively in the plasma of Stroke&G-CSF group, at 1.4 ± 0.85 (pg/ml), and was not detected in the other groups.
| DISCUSSION
The present study demonstrated that RIPC, which was conducted immediately after ischemic stroke in the bilateral hind limbs, 
| 12641
of spleen-derived MMs in brain injury, has attracted great attention (Kim, Yang, Beltran, & Cho, 2014; Miró-Mur et al., 2016; Schmidt et al., 2017; Song et al., 2017) . This study was designed to probe the effects of RIPC on leptomeningeal anastomoses growth, and our results support the concept of monocyte recruitment as playing a critical role in the enhancement of collateral flow (Heil et al., 2002; Sugiyama et al., 2011) .
In addition to collateral flow, increased angiogenesis has been shown to promote neurological and histological improvement after stroke, in particular, demonstrating the outgrowth of new vessels from pre-existing vasculature (Dela Peña et al., 2015; J. Liu et al., 2014) . In this study the angiogenesis marker Ang-1 and Ang-2 were examined at 24 hr after ischemic stroke. The results indicated that neither RIPC nor human G-CSF (100 µg/kg BW) treatment promoted angiogenesis via these factors. In a separate ongoing study, we are analyzing the angiogenic and neurogenic response by repeated daily RIPC in chronic phase after ischemic stroke. Recognizing that G-CSF could exert direct neuroprotective action, we inquired whether remote limb ischemic postconditioning could produce endogenous G-CSF into the peripheral blood and then into the brain. Using ultrasensitive ELISA, we examined mouse G-CSF levels in animal plasma and cerebral tissue to answer this question. The results refuted the hypothesis that endogenous G-CSF is mobilized by RIPC.
Nevertheless, considering the duration of the second protection window of ischemic conditioning (Hausenloy et al., 2016) , the ability of repeated daily RIPC to produce accumulative effects to trigger endogenous G-CSF is worth future investigation.
Currently, the concept of remote ischemic conditioning-induced neuroprotection includes remote ischemic preconditioning (RIPreC), remote ischemic perconditioning (RIPerC), and remote ischemic postconditioning (RIPostC) based on application timing either before ischemia, during ischemia, or during reperfusion of ischemia, respectively (Hess et al., 2013; Lim & Hausenloy, 2012; Wang et al., 2015) . Our 3VO animal model represents a "mixed temporary/permanent" ischemia model that produces clear neocortical infarct and relevant to the most common type of human stroke. 
F I G U R E 5
Western blot for angiopoietins Ang-1 and Ang-2. (a) There were no significant differences of Ang-1 expression between all the groups (n = 5). (b) Ischemic insult upregulated Ang-2 expression in the ischemic cortex, whereas both RIPC and G-CSF treatment showed no further increase (1.8-, 1.7-, 1.8-fold vs. Sham, *p < 0.05, n = 5). Data were expressed as mean ± SEM. Data were normalized to β-actin. G-CSF: granulocyte colony-stimulating factor; RIPC: remote ischemic postconditioning F I G U R E 6 Enzyme-linked immunoassay (ELISA) for mouse G-CSF. (a) Mouse G-CSF level in contralateral cortex of each mouse was 0, as well as the ipsilateral cortex of Sham group. There was an apparent increase of mouse G-CSF in the ipsilateral cortex in Stroke mice, whereas remote ischemic postconditioning and G-CSF significantly decreased the factor compared with Stroke without treatment (***p < 0.001 vs. Sham, ## p < 0.01, ### p < 0.001 vs. Stroke, n = 5). (b) Mouse G-CSF level in plasma of Stroke group showed significant decrease compared with Sham group (*p < 0.05), whereas RIPC and G-CSF treatment both attenuated the downtrend of mouse G-CSF in plasma caused by cerebral ischemic insult (n = 5). Data were expressed as mean ± SEM. G-CSF: granulocyte colony-stimulating factor RIC represents a highly translatable therapy for multiorgan protection against ischemia-reperfusion injury (IRI). A growing number of clinical trials have indicated that RIC exerts therapeutic effects, specifically in the heart (Cao, Zhang, Wang, Xia, & Yang, 2018; Cho et al., 2017 ) and brain (England et al., 2017; Pico et al., 2016) . However, to date, a clear understanding of the mechanism through which RIC exerts its functional benefits remains a key hurdle in its clinical translation. Our present study showed that immediate RIPC reduced cerebral damage by leptomeningeal collateral flow augmentation via spleen-derived MMs recruitment in ischemic stroke mice. Combined with its noninvasive and safe profile, the collateral flow enhancement property of RIPC may facilitate its clinical application for ischemic stroke patients.
